Drugs · acquisition-cost intelligence
ALLZITAL
butalbital and acetaminophen· ingredient acetaminophen· ACETAMINOPHEN 300 mg/1; BUTALBITAL 50 mg/1; ACETAMINOPHEN 325 mg/1; BUTALBITAL 25 mg/1; ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.60430
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other acetaminophen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Acetaminophen Oral Solution | $0.01218 | −$0.59210 |
| Basic Care Daytime Cold and Flu | $0.01348 | −$0.59080 |
| 24-7 Life BY 7-ELEVEN Nighttime Cold and Flu | $0.01504 | −$0.58930 |
| Acetaminophen Extra Strength | $0.01901 | −$0.58530 |
| ADWE Childrens Pain Fever | $0.02109 | −$0.58320 |
| basic care tussin cf severe | $0.02410 | −$0.58020 |
| Acetaminophen 325mg | $0.02520 | −$0.57910 |
| 365 whole foods market acetaminophen | $0.03423 | −$0.57010 |
Medicare Part D coverage · CY2026
On 31 plan formularies · typical tier 2
Prior auth 65% · Step therapy 0% · Quantity limit 42% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.